3 Penny Stocks to Watch Under $1 in December
With December here, penny stocks continue to show renewed momentum. Although trading both penny stocks and blue chips has been difficult in the last few months and especially the past week or so, investors are eager to find small-caps that could see bullish momentum.
To do so, we first have to understand exactly what’s affecting the stock market and how to take advantage. As we all know, right now, the largest impacting factor on stocks is the Omicron variant of Covid-19. While the variant is still little understood, early figures are showing encouraging signs that could help to relieve fears.
News out of Israel is also showing that current vaccines, which were feared to have a reduced effect on Omicron, could still hold up to the task of protecting us. In addition, anecdotal evidence is showing that the variant could cause less severe symptoms than previous variants. So, while we are not out of the woods yet, we can use this information to find the best penny stocks to buy. With all of that in mind, let’s take a look at three to watch right now.
3 Under $1 Penny Stocks to Watch Right Now
- Borqs Technologies Inc. (NASDAQ: BRQS)
- Agile Therapeutics Inc. (NASDAQ: AGRX)
- Adamis Pharmaceuticals Corp. (NASDAQ: ADMP)
Borqs Technologies Inc. (NASDAQ: BRQS)
Borqs Technologies Inc. is a technology penny stock that develops smart device and cloud service solutions. BorqsWare, the company’s software platform that comprises the BorqsWare client software, is utilized in Android phones, tablets, watches, and other devices. This company’s goods are sold to a variety of customers, including mobile chip designers and mobile device equipment manufacturers.
On November 8th, the company was granted land-use rights for 5G/Internet of Things (IoT) solutions. Its wholly-owned subsidiary Borqs Hong Kong Limited was granted land-use rights for around 1.4 million sq. ft. in Huzhou, China, which is located in the Yangtze River Delta. This is one of the fastest-growing industrial regions in the world. These land-use rights are valued at $10.5 million and will be developed in two phases. The total construction space is expected to be 2.2 million sq. ft. and will cost about $125 million.
In the last five days, BRQS stock has increased by a solid 9%. This represents a decent bullish turnaround from its previous yearly performance. While shares are no where near its YTD high of almost $3 at its current price of $0.55, the positive sentiment is encouraging. Noting this recent advancement, will BRQS be on your penny stock watchlist next month?
Agile Therapeutics Inc. (NASDAQ: AGRX)
Agile Therapeutics Inc. is a biotech penny stock that has seen momentum during the last few trading days. One of the reasons behind this…